Our Story

TenZero Biosciences represents the convergence of two distinct areas of research that have taken shape over the past 30 years - novel surgical treatments for spinal cord injury-associated neuropathic pain and proteomic technologies for exploring the underlying drivers.  

Building on insights from human pain-causal tissue, TenZero's Human Pain Proteome Database reveals new targets for neuropathic pain and provides the basis for new drugs            and biologics.      

The TenZero team combines extensive clinical, drug discovery and development, biotechnology, informatics, and business expertise to drive innovation and improve the lives of those with neuropathic pain.